Atlantic clinical trial network gets $2.5-million boost from national research institute
Halifax, NS – Clinical trials are an important tool in finding new treatments and cures for patients. Nova Scotia Health officials reported that the Atlantic Clinical Trials Network (ACTN) was awarded up to $2.5 million from the Canadian Institutes of Health Research via its participation to CTTP (Clinical Trials Training Programs)-CANTRAIN.
Government of Canada announces new clinical trials consortium, training platforms, and research projects to improve the health of Canadians
Clinical trials allow researchers to assess the safety and effectiveness of new drugs, treatments, and therapies for our population. It is through these studies and their collaborative networks, that medical innovation in Canada continues to evolve.
Reinforcing Canada’s clinical trials infrastructure, training, and research
Clinical trials are an essential part of the healthcare sector and a crucial component of medical research and innovation. Clinical trials allow researchers to assess if new drugs, treatments, and therapies are safe and effective for the population.
Significant funding to maximize access and drive excellence in clinical trials in Quebec and Canada
RI-MUHC researchers will lead or co-lead multiple projects awarded a total of $55 million from the Canadian Institutes of Health Research
Canadian Consortium of Clinical Trials Training receives CIHR Funding
Halifax, NS – The Atlantic Clinical Trials Network (ACTN) will receive approximately $2.5 million for the creation of various student training opportunities at the masters, PhD, postdoctoral and postdoctoral fellow levels, along with the creation of six new positions in Atlantic Canada focused on the development and coordination of clinical trial professional training within the region.